Vitaspring Biomedical VSBC
OTC VSBC
$0.03 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Vitaspring Biomedical (VSBC) Debt Ratio (2017 - 2026)

Updated

Vitaspring Biomedical's Debt Ratio came in at 162.66 for fiscal Q2 2027 (quarter ended Jul 31, 2026).

Analysis

Vitaspring Biomedical (VSBC) Debt Ratio (2017 - 2026) Analysis & Trends

Going back to fiscal Q3 2018, Vitaspring Biomedical's Debt Ratio data covers 5 quarters.

  • The fiscal Q2 2027 figure represents the lowest quarterly Debt Ratio since fiscal Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,158.62 Bn 1,127.21 Bn 19.71 Bn 0.39
2 Johnson & Johnson 624.60 Bn 543.13 Bn 17.26 Bn 0.24
3 AbbVie 511.56 Bn 484.67 Bn 12.70 Bn 0.52
4 Merck 366.61 Bn 320.99 Bn 12.21 Bn 0.42
5 Novartis Ag 297.15 Bn 261.14 Bn 11.24 Bn 0.08
6 Astrazeneca 260.94 Bn 234.63 Bn 12.86 Bn 0.28
7 Amgen 234.46 Bn 189.86 Bn 7.24 Bn 0.60
8 Gilead Sciences 193.49 Bn 167.69 Bn 6.22 Bn 0.53
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 0.31
10 Vitaspring Biomedical 6.21 Mn 6.19 Mn - 162.66
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 162.66
Jul 31, 2020 0.49
Apr 30, 2020 9.70
Oct 31, 2018 11.84
Oct 31, 2017 4.08
API Access

Vitaspring Biomedical Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=VSBC&period=max&api_key=YOUR_API_KEY